X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24729) 24729
Newspaper Article (830) 830
Newsletter (149) 149
Book Chapter (69) 69
Magazine Article (46) 46
Book / eBook (31) 31
Web Resource (21) 21
Trade Publication Article (13) 13
Conference Proceeding (12) 12
Transcript (12) 12
Dissertation (7) 7
Book Review (3) 3
Report (3) 3
Government Document (2) 2
Publication (2) 2
Streaming Video (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19779) 19779
female (10020) 10020
male (9213) 9213
immunoglobulins, intravenous - therapeutic use (8778) 8778
immunoglobulins (7831) 7831
adult (5827) 5827
middle aged (5164) 5164
animals (4685) 4685
immunology (4682) 4682
treatment outcome (3915) 3915
intravenous immunoglobulin (3254) 3254
aged (3189) 3189
child (2838) 2838
antibodies (2519) 2519
therapy (2516) 2516
mice (2428) 2428
adolescent (2337) 2337
care and treatment (2304) 2304
immunoglobulin g (2264) 2264
health aspects (2171) 2171
patients (2129) 2129
child, preschool (2061) 2061
clinical neurology (2054) 2054
pediatrics (2014) 2014
hematology (2010) 2010
immunosuppressive agents - therapeutic use (1954) 1954
disease (1939) 1939
antibodies, monoclonal - therapeutic use (1926) 1926
proteins (1903) 1903
immunotherapy (1819) 1819
retrospective studies (1628) 1628
immunologic factors - therapeutic use (1614) 1614
research (1600) 1600
infant (1598) 1598
analysis (1589) 1589
antigens (1569) 1569
transplantation (1554) 1554
pharmacology & pharmacy (1546) 1546
children (1511) 1511
medicine & public health (1430) 1430
medicine, general & internal (1424) 1424
infections (1421) 1421
diagnosis (1378) 1378
neurosciences (1367) 1367
rheumatology (1340) 1340
risk factors (1340) 1340
inflammation (1321) 1321
oncology (1294) 1294
immunoglobulin g - therapeutic use (1289) 1289
rituximab (1282) 1282
immunoglobulin (1279) 1279
medicine (1268) 1268
monoclonal antibodies (1260) 1260
surgery (1239) 1239
medical research (1200) 1200
drug therapy (1193) 1193
infectious diseases (1170) 1170
immunoglobulins, intravenous - administration & dosage (1168) 1168
pregnancy (1160) 1160
clinical trials (1148) 1148
cytokines (1124) 1124
double-blind (1123) 1123
studies (1110) 1110
medicine, research & experimental (1099) 1099
intravenous administration (1088) 1088
young adult (1083) 1083
infection (1063) 1063
lymphocytes (1053) 1053
research article (1044) 1044
time factors (1041) 1041
drug therapy, combination (1033) 1033
cancer (1022) 1022
allergy (1019) 1019
autoantibodies (1019) 1019
immunoglobulin g - blood (1011) 1011
follow-up studies (997) 997
internal medicine (994) 994
abridged index medicus (976) 976
infant, newborn (969) 969
immunoglobulin g - immunology (949) 949
neurology (939) 939
dermatology (934) 934
autoimmune diseases (923) 923
mortality (922) 922
autoimmunity (912) 912
immune system (909) 909
adrenal cortex hormones - therapeutic use (902) 902
prognosis (879) 879
multidisciplinary sciences (877) 877
diagnosis, differential (860) 860
disease models, animal (856) 856
plasmapheresis (854) 854
efficacy (843) 843
ivig (835) 835
expression (832) 832
management (827) 827
drug dosages (811) 811
aged, 80 and over (807) 807
immunoglobulins, intravenous - adverse effects (806) 806
recurrence (790) 790
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24651) 24651
French (429) 429
Spanish (212) 212
Japanese (197) 197
German (194) 194
Chinese (75) 75
Italian (75) 75
Polish (54) 54
Russian (51) 51
Hebrew (23) 23
Czech (20) 20
Dutch (17) 17
Hungarian (17) 17
Danish (16) 16
Portuguese (15) 15
Swedish (9) 9
Norwegian (8) 8
Serbian (7) 7
Turkish (7) 7
Croatian (6) 6
Ukrainian (6) 6
Korean (5) 5
Slovak (5) 5
Bulgarian (4) 4
Romanian (4) 4
Finnish (2) 2
Arabic (1) 1
Bosnian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 11/2016, Volume 2016, Issue 11, p. CD008630
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2016, Issue 10, p. CD002827
Background Serum monoclonal anti‐myelin‐associated glycoprotein (anti‐MAG) antibodies may be pathogenic in some people with immunoglobulin M (IgM) paraprotein... 
Immunoglobulin M | Immunosuppressive Agents | Paraproteins | IgM paraproteinaemic demyelinating neuropathy | Rituximab | Myelin‐Associated Glycoprotein | Plasma Exchange | Peripheral neuropathy | Randomized Controlled Trials as Topic | Neurology | Peripheral Nervous System Diseases | Immunotherapy | Paraproteinemias | Medicine General & Introductory Medical Sciences | Demyelinating Diseases | Immunoglobulins, Intravenous | Paraproteinaemic neuropathy | RITUXIMAB TREATMENT | Immunotherapy [methods] | LONG-TERM RESPONSE | WALDENSTROMS MACROGLOBULINEMIA | Humans | Myelin-Associated Glycoprotein [immunology] | INTERMITTENT CYCLOPHOSPHAMIDE | Immunosuppressive Agents [therapeutic use] | Demyelinating Diseases [immunology; therapy] | INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | Peripheral Nervous System Diseases [immunology; therapy] | Immunoglobulin M [immunology] | MEDICINE, GENERAL & INTERNAL | INTERFERON-ALPHA | Paraproteinemias [immunology; therapy] | INTRAVENOUS IMMUNOGLOBULIN | Immunoglobulins, Intravenous [therapeutic use] | MONOCLONAL GAMMOPATHY | Plasma Exchange [methods] | PLACEBO-CONTROLLED TRIAL | Paraproteins [immunology] | PLASMA-CELL DYSCRASIA | Paraproteinemias - immunology | Immunotherapy - methods | Demyelinating Diseases - therapy | Immunosuppressive Agents - therapeutic use | Paraproteinemias - therapy | Peripheral Nervous System Diseases - therapy | Immunoglobulin M - immunology | Rituximab - therapeutic use | Myelin-Associated Glycoprotein - immunology | Immunoglobulin M - blood | Immunoglobulins, Intravenous - therapeutic use | Plasma Exchange - methods | Demyelinating Diseases - immunology | Peripheral Nervous System Diseases - immunology | Paraproteins - immunology
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 6, p. e0198184
... of splenectomy (Splx) as the first and still successfully used therapeutic measure in management of immune thrombocytopenia (ITP) [1]. The second therapeutic measure... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2017, Volume 2019, Issue 10, p. CD003280
Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a disease that causes progressive or relapsing and remitting weakness and... 
Immunologic Factors | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic inflammatory demyelinating polyradiculopathy | Immunosuppressive Agents | Chronic inflammatory demyelinating polyradiculoneuropathy | Interferon beta‐1a | Treatment Outcome | Immunosuppressive and immunomodulatory treatment | Randomized Controlled Trials as Topic | Neurology | Interferon‐beta | Anti‐Inflammatory Agents | Azathioprine | Methotrexate | Medicine General & Introductory Medical Sciences | Immunoglobulins, Intravenous | Peripheral Neuropathy | SYSTEMIC-LUPUS-ERYTHEMATOSUS | Interferon-beta [therapeutic use] | Immunologic Factors [therapeutic use] | Humans | GUILLAIN-BARRE-SYNDROME | Immunosuppressive Agents [therapeutic use] | Anti-Inflammatory Agents [therapeutic use] | Azathioprine [therapeutic use] | RANDOMIZED CONTROLLED TRIAL | DISEASE-MODIFYING THERAPY | MEDICINE, GENERAL & INTERNAL | Interferon beta-1a | HIGH-DOSE CYCLOPHOSPHAMIDE | INTRAVENOUS IMMUNOGLOBULIN | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [drug therapy] | TERM-FOLLOW-UP | PLACEBO-CONTROLLED TRIAL | STEM-CELL TRANSPLANTATION | Methotrexate [therapeutic use] | MYCOPHENOLATE-MOFETIL | Interferon-beta - therapeutic use | Azathioprine - therapeutic use | Interferon beta-1a - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Immunosuppressive Agents - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Anti-Inflammatory Agents - therapeutic use | Methotrexate - therapeutic use | Immunologic Factors - therapeutic use
Journal Article